Condition: MINOCA · Atrial Fibrillation · Sponsor: Insel Gruppe AG, University Hospital Bern
Myocardial infarction with non-obstructive coronary arteries (MINOCA) (i.e.\<50% stenoses) on coronary angiography) is an underappreciated clinical entity concerning 5-6% of patients with acute myocardial infarction. Approximately 50% of these patients remain without appropriate diagnosis and treatment. The MINOCA study aims at systematically assessing the frequency of underlying pathologies of MINOCA and outcomes with a multidisciplinary etiologic work-up and follow-up of 5 years including, for the first time, an implantable cardiac monitor (ICM) to assess the frequency of atrial fibrillation as underlying cause for MINOCA.
This description comes directly from the study's public registry record.
Lorenz Räber, MD, PhD · +41 31 632 50 00 · lorenz.raeber@insel.ch
Sarah Bär, MD · sarah.baer@insel.ch
Always discuss trial participation with your own doctor first.
| Bern University Hospital Inselspital | Bern, Switzerland | Recruiting |
| University Hospital Zurich USZ | Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05326828